These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 6200114

  • 1. Differentiation of the cardiac and pulmonary toxicity of monocrotaline, a pyrrolizidine alkaloid.
    Lafranconi WM, Duhamel RC, Brendel K, Huxtable RJ.
    Biochem Pharmacol; 1984 Jan 15; 33(2):191-7. PubMed ID: 6200114
    [Abstract] [Full Text] [Related]

  • 2. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
    Molteni A, Ward WF, Ts'ao CH, Hinz JM.
    Biochem Pharmacol; 1989 Aug 01; 38(15):2411-9. PubMed ID: 2547380
    [Abstract] [Full Text] [Related]

  • 3. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ, Hubbard AK, Huxtable RJ.
    J Toxicol Environ Health; 1989 Aug 01; 28(4):445-60. PubMed ID: 2531804
    [Abstract] [Full Text] [Related]

  • 4. Monocrotaline-induced cardiopulmonary damage in rats: amelioration by the angiotensin-converting enzyme inhibitor CL242817.
    Molteni A, Ward WF, Ts'ao CH, Solliday NH.
    Proc Soc Exp Biol Med; 1986 Sep 01; 182(4):483-93. PubMed ID: 3016747
    [Abstract] [Full Text] [Related]

  • 5. The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole.
    Ganey PE, Fink GD, Roth RA.
    Toxicol Appl Pharmacol; 1985 Mar 30; 78(1):55-62. PubMed ID: 2930913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum copper concentration as an index of cardiopulmonary injury in monocrotaline-treated rats.
    Molteni A, Ward WF, Ts'ao CH, Fitzsimons EJ.
    Ann Clin Lab Sci; 1988 Mar 30; 18(6):476-83. PubMed ID: 3149170
    [Abstract] [Full Text] [Related]

  • 11. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine.
    Molteni A, Ward WF, Ts'ao CH, Solliday NH, Dunne M.
    Proc Soc Exp Biol Med; 1985 Oct 30; 180(1):112-20. PubMed ID: 2994075
    [Abstract] [Full Text] [Related]

  • 12. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
    Todd L, Mullen M, Olley PM, Rabinovitch M.
    Pediatr Res; 1985 Jul 30; 19(7):731-7. PubMed ID: 3161000
    [Abstract] [Full Text] [Related]

  • 13. Changes in ventricular 1,2-diacylglycerol content in rats following monocrotaline treatment.
    Okumura K, Kondo J, Shimizu K, Yoshino M, Toki Y, Hashimoto H, Ito T.
    Cardiovasc Res; 1992 Jun 30; 26(6):626-30. PubMed ID: 1280532
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jul 30; 109(3):421-31. PubMed ID: 1830177
    [Abstract] [Full Text] [Related]

  • 15. Chemical sympathectomy and serotonin inhibition reduce monocrotaline-induced right ventricular hypertrophy in rats.
    Tucker A, Bryant SE, Frost HH, Migally N.
    Can J Physiol Pharmacol; 1983 Apr 30; 61(4):356-62. PubMed ID: 6222785
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM, Keane PM, Suyama KL, Gauthier D.
    Thorax; 1982 Feb 30; 37(2):88-96. PubMed ID: 6281933
    [Abstract] [Full Text] [Related]

  • 17. Monocrotaline pneumotoxicity in mice.
    Molteni A, Ward WF, Ts'ao CH, Solliday NH.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989 Feb 30; 57(3):149-55. PubMed ID: 2570481
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Right ventricular performance after monocrotaline-induced pulmonary hypertension.
    Werchan PM, Summer WR, Gerdes AM, McDonough KH.
    Am J Physiol; 1989 May 30; 256(5 Pt 2):H1328-36. PubMed ID: 2524170
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.